Pegylated interferon for chronic hepatitis C in children affects growth and body composition: Results from the pediatric study of hepatitis C (PEDS-C) trial-Reference-Cited by-同舟云学术

Pegylated interferon for chronic hepatitis C in children affects growth and body composition: Results from the pediatric study of hepatitis C (PEDS-C) trial

Published:2012-07-06 Issue:2 Volume:56 Page:523-531
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Jonas Maureen M.,Balistreri William,Gonzalez-Peralta Regino P.,Haber Barbara,Lobritto Steven,Mohan Parvathi,Molleston Jean P.,Murray Karen F.,Narkewicz Michael R.,Rosenthal Philip,Schwarz Kathleen B.,Barton Bruce A.,Shepherd John A.,Mitchell Paul D.,Duggan Christopher

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.25690/fullpdf

Reference19 articles.

1. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease;Bortolotti;Gastroenterology,2008

2. Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C;González-Peralta;J Pediatr Gastroenterol Nutr,2009

3. Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children;Rodrigue;HEPATOLOGY,2011

4. Impact of chronic hepatitis B and interferon-alfa therapy on growth of children;Comanor;J Vir Hepat,2001

5. Influence of recombinant interferon alpha on nutritional status and growth pattern in children with chronic viral hepatitis;Gottrand;Eur J Pediatr,1996

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Influence of Treatment With Sofosbuvir/Velpatasvir on Children’s Growth—Results of the PANDAA-PED Study;Pediatric Infectious Disease Journal;2024-09-04

2. Expert Consensus on the Prevention and Treatment of Chronic Hepatitis B in Children;Infectious Diseases & Immunity;2024-06-12

3. Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B;Hepatology International;2024-02-20

4. Efficacy of pegylated interferon α-2b plus entecavir therapy and predictors of treatment success in children with chronic hepatitis B;Frontiers in Immunology;2023-12-04

5. Efficiency and safety of sofosbuvir in Bangladeshi children with chronic hepatitis C virus infection;iLIVER;2023-09